Skip to content

Communication About the Disclosure of Hereditary Cancer to Children: A Scoping Review Protocol

Communication About the Disclosure of Hereditary Cancer to Children: A Scoping Review Protocol - Communication About the Disclosure of Hereditary Cancer to Children: A Scoping Review Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000057976
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Cancer

Interventions

None listed

Sponsors

Niigata University
Lead Sponsor
Saint Lukes International University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The Population-Concept-Context (PCC) framework recommended in the JBI methodology was applied to formulate the review questions and establish the eligibility criteria. Population: Children aged 18 years or younger who are diagnosed with or suspected of having any hereditary tumor, as well as their families and healthcare providers. Concept: Disclosure support for communicating hereditary tumor-related information to children and adolescents. This review mapped the characteristics of disclosure support, including the type of support, target age, target disease, resource format, delivery method, content, and whether the support had been evaluated. Context: Settings or environments in which disclosure support for communicating hereditary tumor-related information to children may be provided or used. These included clinical care, genetic counseling, oncology care, pediatric care, psycho-oncology, community-based services, and family or home settings. Types of evidence sources eligible for inclusion: This review included primary research studies and relevant support resources that described the development or evaluation of resources, interventions, or professional support for disclosing hereditary tumor-related information to children and adolescents.

Exclusion criteria

Exclusion criteria: 1)Studies for which only the title and abstract are available, and the full text cannot be accessed, will be excluded. 2)Studies including data from participants aged 18 years or older will be excluded if 20% or more of the participants are 18 years old or above.

Design outcomes

Primary

MeasureTime frame
The current status of communication in disclosure and its support, and the effectiveness of that support.

Countries

Japan

Contacts

Public ContactKaito Sugima

Niigata University Department of Nursing, School of Health Sciences Faculty of Medicine.

b24a302b@mail.cc.niigata-u.ac.jp0252272364

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026